1. Home
  2. IRIX vs ICCC Comparison

IRIX vs ICCC Comparison

Compare IRIX & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • ICCC
  • Stock Information
  • Founded
  • IRIX 1989
  • ICCC 1982
  • Country
  • IRIX United States
  • ICCC United States
  • Employees
  • IRIX N/A
  • ICCC N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRIX Health Care
  • ICCC Health Care
  • Exchange
  • IRIX Nasdaq
  • ICCC Nasdaq
  • Market Cap
  • IRIX 23.8M
  • ICCC 28.0M
  • IPO Year
  • IRIX 1996
  • ICCC 1987
  • Fundamental
  • Price
  • IRIX $1.72
  • ICCC $3.66
  • Analyst Decision
  • IRIX Hold
  • ICCC
  • Analyst Count
  • IRIX 1
  • ICCC 0
  • Target Price
  • IRIX $2.00
  • ICCC N/A
  • AVG Volume (30 Days)
  • IRIX 44.0K
  • ICCC 14.5K
  • Earning Date
  • IRIX 11-12-2024
  • ICCC 11-13-2024
  • Dividend Yield
  • IRIX N/A
  • ICCC N/A
  • EPS Growth
  • IRIX N/A
  • ICCC N/A
  • EPS
  • IRIX N/A
  • ICCC N/A
  • Revenue
  • IRIX $48,431,000.00
  • ICCC $23,838,002.00
  • Revenue This Year
  • IRIX N/A
  • ICCC N/A
  • Revenue Next Year
  • IRIX $5.44
  • ICCC N/A
  • P/E Ratio
  • IRIX N/A
  • ICCC N/A
  • Revenue Growth
  • IRIX N/A
  • ICCC 46.37
  • 52 Week Low
  • IRIX $1.27
  • ICCC $3.34
  • 52 Week High
  • IRIX $3.65
  • ICCC $5.59
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 55.76
  • ICCC 54.28
  • Support Level
  • IRIX $1.65
  • ICCC $3.40
  • Resistance Level
  • IRIX $1.85
  • ICCC $3.64
  • Average True Range (ATR)
  • IRIX 0.13
  • ICCC 0.16
  • MACD
  • IRIX 0.04
  • ICCC 0.01
  • Stochastic Oscillator
  • IRIX 67.16
  • ICCC 65.12

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: